Developing Cleaning-in-Place Protocols
March 16, 2016 - Cytiva

Cleaning conditions for chromatography media can be screened in a

Antibody Production in Microbial Hosts
February 18, 2016 - BioPharm Intl.

The authors review the status of expression of antibodies in microbial hosts and present the recent advances in the production of aglycosylated antibodi

Innovative Therapies Require Modern Manufacturing Systems
February 18, 2016 - BioPharm Intl.

FDA and industry see progress and challenges in bringing cutting-edge medicines to patients.

By Jill Wechsler

A Q&A With Jeff Carter on Trends in Single-Use Technologies
February 18, 2016 - Process Development Forum

Process Development Forum speaks with Jeff Carter, Strategic Projects Leader at Cytiva, and first Vice Chair on the executive board of the Bio-

Framing Biopharma Success in 2016
February 4, 2016 - BioPharm Intl.

Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.

By Rita C. Peters

KUBio modular biopharm facility built in Germany, assembled in Ch


January 22, 2016 - Cytiva

Cytiva is supplying a full biopharmaceutical processing so

Tools for Continuous Bioprocessing Development
January 21, 2016 - BioPharm Intl.

Could perfusion microbioreactors bring more agility to biomanufacturing?

By Rajeev J. Ram

In semiconductor manufact

Going Small to Achieve Success on the Commercial Scale
January 21, 2016 - BioPharm Intl.

Scale-down modeling is instrumental in supporting the development of downstream biopharma manufacturing processes.

By Cynthia A. Cha

Biopharma in 2015: A Year for Approvals and Innovations
January 14, 2016 - Process Development Forum

Insiders

mAbs to Watch in 2016
January 10, 2016 - BioPharm Intl.

By Randi Hernandez

Of the 45 new molecular entities and new therapeutic biological products approved by FDA in 2015, nine products were monoclonal an

Previous PageNext Page